Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis.

Bengtsson AA, Trygg J, Wuttge DM, Sturfelt G, Theander E, Donten M, Moritz T, Sennbro CJ, Torell F, Lood C, Surowiec I, Rännar S, Lundstedt T.

PLoS One. 2016 Jul 21;11(7):e0159384. doi: 10.1371/journal.pone.0159384. eCollection 2016.

2.

Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod.

Svensson LD, Sennbro CJ, Svanström C, Hansson GP.

Bioanalysis. 2015;7(2):179-91. doi: 10.4155/bio.14.259.

PMID:
25587835
3.

Quantitative determination of the anti-tumor agent tasquinimod in human urine by liquid chromatography-tandem mass spectrometry.

van de Merbel NC, Walland P, Tiensuu M, Sennbro CJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 15;961:42-8. doi: 10.1016/j.jchromb.2014.05.007. Epub 2014 May 14.

PMID:
24858264
4.

Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum.

Sennbro CJ, Knutsson M, van Amsterdam P, Timmerman P.

Bioanalysis. 2011 Nov;3(21):2393-9. doi: 10.4155/bio.11.239.

PMID:
22074281
5.

Anticoagulant counter ion impact on bioanalytical LC-MS/MS assay performance: additional validation required?

Sennbro CJ, Knutsson M, Timmerman P, van Amsterdam P.

Bioanalysis. 2011 Nov;3(21):2389-91. doi: 10.4155/bio.11.240. No abstract available.

PMID:
22074280
6.
7.

Bioanalysis in clinical development of tasquinimod using liquid chromatography/tandem mass spectrometry.

Hansson GP, Olin M, Svanström C, Svensson LD, Sennbro CJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Nov 15;879(30):3401-6. doi: 10.1016/j.jchromb.2011.09.013. Epub 2011 Sep 13. Erratum in: J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jun 15;899:167.

PMID:
21963277
8.

Diagnostic properties of metabolic perturbations in rheumatoid arthritis.

Madsen RK, Lundstedt T, Gabrielsson J, Sennbro CJ, Alenius GM, Moritz T, Rantapää-Dahlqvist S, Trygg J.

Arthritis Res Ther. 2011 Feb 8;13(1):R19. doi: 10.1186/ar3243.

9.

The GSTP1 Ile105 Val polymorphism modifies the metabolism of toluene di-isocyanate.

Broberg KE, Warholm M, Tinnerberg H, Axmon A, Jönsson BA, Sennbro CJ, Littorin M, Rannug A.

Pharmacogenet Genomics. 2010 Feb;20(2):104-11. doi: 10.1097/FPC.0b013e328334fb84.

PMID:
20032816
10.

Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum.

Timmerman P, Luedtke S, van Amsterdam P, Brudny-Kloeppel M, Lausecker B, Fischmann S, Globig S, Sennbro CJ, Jansat JM, Mulder H, Thomas E, Knutsson M, Kasel D, White SA, Kall MA, Mokrzycki-Issartel N, Freisleben A, Romero F, Andersen MP, Knebel N, de Zwart M, Laakso S, Hucker RS, Schmidt D, Gordon B, Abbott R, Boulanger P.

Bioanalysis. 2009 Sep;1(6):1049-56. doi: 10.4155/bio.09.108.

11.

Aniline in hydrolyzed urine and plasma--possible biomarkers for phenylisocyanate exposure.

Tinnerberg H, Sennbro CJ, Jönsson BA.

J Occup Environ Hyg. 2008 Oct;5(10):629-32. doi: 10.1080/15459620802275411.

PMID:
18666023
12.

Eye and airway symptoms in low occupational exposure to toluene diisocyanate.

Littorin M, Axmon A, Broberg K, Sennbro CJ, Tinnerberg H.

Scand J Work Environ Health. 2007 Aug;33(4):280-5.

13.
14.

Biological monitoring of exposure to 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate.

Sennbro CJ, Lindh CH, Mattsson C, Jönsson BA, Tinnerberg H.

Int Arch Occup Environ Health. 2006 Sep;79(8):647-53. Epub 2006 Feb 28.

PMID:
16506043
15.

Upper reference limits for biomarkers of exposure to aromatic diisocyanates.

Sennbro CJ, Littorin M, Tinnerberg H, Jönsson BA.

Int Arch Occup Environ Health. 2005 Aug;78(7):541-6. Epub 2005 Jul 2.

PMID:
15995877
16.

Biological monitoring of exposure to toluene diisocyanate.

Sennbro CJ, Lindh CH, Tinnerberg H, Welinder H, Littorin M, Jönsson BA.

Scand J Work Environ Health. 2004 Oct;30(5):371-8. Erratum in: Scand J Work Environ Health. 2005 Feb;31(1):84.

17.

Determination of isocyanates in air using 1-(2-methoxyphenyl)piperazine-impregnated filters: long-term sampling performance and field comparison with impingers with dibutylamine.

Sennbro CJ, Ekman J, Lindh CH, Welinder H, Jönsson BA, Tinnerberg H.

Ann Occup Hyg. 2004 Jul;48(5):415-24. Epub 2004 Jul 7.

PMID:
15240338
18.

A survey of airborne isocyanate exposure in 13 Swedish polyurethane industries.

Sennbro CJ, Lindh CH, Ostin A, Welinder H, Jönsson BA, Tinnerberg H.

Ann Occup Hyg. 2004 Jul;48(5):405-14. Epub 2004 Jul 7.

PMID:
15240337
19.

Identification and characterisation of adducts between serum albumin and 4,4'-methylenediphenyl diisocyanate (MDI) in human plasma.

Johannesson G, Sennbro CJ, Willix P, Lindh CH, Jönsson BA.

Arch Toxicol. 2004 Jul;78(7):378-83. Epub 2004 Mar 6.

PMID:
15007542

Supplemental Content

Loading ...
Support Center